Findings suggest targeting neuro-immune pathway could lead to strategies for managing diabetes, obesity or some types of ...

A study published in Science by the Champalimaud Foundation reveals a surprising new role for the immune system. During ...

When we think about the immune system, we usually associate it with fighting infections. However, a study published in Science by the Champalimaud ...

Life without a pancreas involves treatments to replace organ function. Learn how different surgical techniques affect overall ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Objective—Glucagon-like peptide 1 (GLP-1 ... Previous studies have focused on the improvements in β-cell function, while the inhibition of α-cell secretion has received less attention.

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

PRNewswire/ -- (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today ...

With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

The following is a summary of “Treatment of Hypothalamic Obesity With GLP-1 Analogs,” published in the November 2024 issue of Endocrinology by Dimitri and Roth. Damage to hypothalamic nuclei or ...

As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two ...